MDPI and ACS Style
Kong, D.; Mai, Z.; Chen, Y.; Luo, L.; Liu, H.; Zhao, L.; Huang, R.; Wang, S.; Chen, R.; Zhou, H.;
et al. ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation. Pharmaceuticals 2022, 15, 1526.
https://doi.org/10.3390/ph15121526
AMA Style
Kong D, Mai Z, Chen Y, Luo L, Liu H, Zhao L, Huang R, Wang S, Chen R, Zhou H,
et al. ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation. Pharmaceuticals. 2022; 15(12):1526.
https://doi.org/10.3390/ph15121526
Chicago/Turabian Style
Kong, Danli, Zhenhua Mai, Yongze Chen, Ling Luo, Hao Liu, Le Zhao, Ruixian Huang, Shuang Wang, Rong Chen, Hao Zhou,
and et al. 2022. "ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation" Pharmaceuticals 15, no. 12: 1526.
https://doi.org/10.3390/ph15121526